СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN

Show other versions (1)

In patients with arterial hypertension (HT) heart is affected earlier and more often than other target organs, left ventricular hypertrophy (LVH) develops. Considering the proven link between the presence of LVH and increased cardiovascular risk, the deterioration of the clinical course and prognosi...

Full description

Bibliographic Details
Main Authors:	I. I. Chukaeva, Ya. G. Spiryakina
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	arterial hypertension left ventricular hypertrophy antihypertensive therapy cardioprotection losartan
Online Access:	https://www.rpcardio.com/jour/article/view/277

Similar Items

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

Clinical efficacy and cardioprotective capabilities of olmesartan and lercanidipine in the form of monotherapy and with their combined use in patients with arterial hypertension 1-2 degree
by: A. G Evdokimova, et al.
Published: (2017-03-01)

Three-year dynamics of left ventricular structural parameters in patients with resistant arterial hypertension on four-component therapy
by: О. О. Matova, et al.
Published: (2020-12-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Antihypertensive therapy and left ventricular hypertrophy prevention in patients with essential arterial hypertension and high treatment compliance
by: N. A. Koziolova, et al.
Published: (1970-01-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

Influence of losartan on structural and functional remodelling of cardiovascular system in comorbidity of chronic obstructive lung disease and arterial hypertension
by: V. A. Nikitin, et al.
Published: (2016-10-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

Non-dipper treated hypertensive patients do not have increased cardiac structural alterations
by: Magrini Fabio, et al.
Published: (2003-02-01)

Left ventricle myocardial hypertrophy in women with arterial hypertension: justification of medical tactics
by: O. A Kislyak, et al.
Published: (2015-06-01)

Early left ventricular remodelling criteria and antihypertensive therapy effectiveness
by: L. L. Kirichenko, et al.
Published: (2011-06-01)

Left ventricular hypertrophy in arterial hypertension and arrhythmia risk
by: I. G. Fomina, et al.
Published: (1970-01-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

THE PREVALENCE OF ARTERIAL HYPERTENSION AND THE SPECIFIC FEATURES OF DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN RADIATION-EXPOSED PERSONS
by: S. K. Kukushkin, et al.
Published: (2015-10-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension
by: A. I. Kochetkov, et al.
Published: (2019-07-01)

Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial
by: I E Chazova, et al.
Published: (2013-10-01)

Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
by: E. S. Sitkova, et al.
Published: (2021-03-01)

DYNAMICS OF LEFT VENTRICULAR PARAMETERS IN THE LONG-TERM TREATMENT OF RENAL PARENCHYMATOUS ARTERIAL HYPERTENSION
by: N. Yu. Borovkova, et al.
Published: (2013-02-01)

PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION
by: E. I. Tarlovskaya, et al.
Published: (2015-12-01)

Left atrial size in patients with arterial hypertension
by: Milutinović Suzana, et al.
Published: (2006-01-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Correlation between left ventricular hypertrophy and diastolic dysfunction in arterial hypertension
by: Z К Trushinsky, et al.
Published: (2003-03-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

Achievement of the main goals of therapy by using of a triple fixed combination of amlodipine, indapamide and perindopril (Co-Dalneva®) in patients with arterial hypertension
by: Chukaeva I.I., et al.
Published: (2017-05-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

Sensitivity and specificity of ECG-LVH indexes in the group of patients above 60 years old with arterial hypertension
by: Jagoda Młynarczyk, et al.
Published: (2016-02-01)

HYPERTENSIVE HEART DISEASE IN COVERT ARTERIAL HYPERTENSION OF A LARGE FACTORY EMPLOYEE
by: A. N. Britov, et al.
Published: (2015-02-01)

COMBINED ANTIHYPERTENSIVE THERAPY: FOCUS ON A FIXED-DOSE COMBINATION OF AN ACE INHIBITOR AND A DIURETIC
by: Z. T. Astakhova, et al.
Published: (2010-10-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2011-12-01)

The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension
by: N Sh Zagidullin, et al.
Published: (2009-12-01)

Clinical equivalence of amlodipine medications in arterial hypertension patients
by: L. I. Markova, et al.
Published: (2005-08-01)

Antihypertensive combination therapy effects on cardiac remodelling in elderly patients
by: L. Kh. Gadzhieva, et al.
Published: (2013-10-01)

Target organ damage in stress-induced arterial hypertension
by: O. N. Antropova, et al.
Published: (2009-04-01)